Skip to main content


Fig. 2 | Clinical and Translational Allergy

Fig. 2

From: An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity

Fig. 2

Diagnostic procedures for the diagnosis of DHRs. *Non severe uncomplicated exanthemas. **This category include more severe exanthemas, such as those with high extent and density of skin lesions and long duration, complication or danger signs. It includes also acute generalized exanthematic pustulosis, drug reaction with eosinophilia and systemic symptoms, Stevens Johnson Syndrome or toxic epidermal necrolysis. In specific cases, skin tests may be considered for identification of culprit among several used drugs. ***For NSAID and non-BL antibiotics, the diagnostic value of skin tests is not well defined. In case of isolated urticaria, a DPT can be performed directly. ****Validated in vitro tests recommended before skin tests if history of severe reaction or if skin tests are not possible or refused. They may confirm hypersensitivity only together with convincing history and/or other tests. Practically, specific IgE are mainly used for suspicion of hypersensitivity to BL antibiotics. ******In the pediatric population, it has been shown that a drug provocation test can be performed directly, without skin test before, in children with a non severe uncomplication exanthemss. If there is any doubt, skin tests should be performed before drug provocation test

Back to article page